Published in Neuroepidemiology on August 06, 2003
Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol (2012) 2.48
Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ (2008) 1.55
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics (2007) 1.20
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
The epidemiology of frontotemporal dementia. Int Rev Psychiatry (2013) 1.09
Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat (2008) 1.03
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology (2008) 1.00
Clinical features and multidisciplinary approaches to dementia care. J Multidiscip Healthc (2011) 0.99
The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis. Ont Health Technol Assess Ser (2014) 0.92
Vascular dementia: prevention and treatment. Clin Interv Aging (2006) 0.87
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Front Aging Neurosci (2015) 0.87
Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria. Front Aging Neurosci (2014) 0.86
MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms. Front Mol Neurosci (2014) 0.83
Cardiovascular risk factors and frontotemporal dementia: a case-control study. Transl Neurodegener (2014) 0.78
Proactive approach in detecting elderly subjects with cognitive decline in general practitioners' practices. Dement Geriatr Cogn Dis Extra (2011) 0.77
Visual rating versus volumetry to detect frontotemporal dementia. Dement Geriatr Cogn Disord (2011) 0.77
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Evidence based medicine: an approach to clinical problem-solving. BMJ (1995) 24.65
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
A reevaluation of the duration of survival after the onset of dementia. N Engl J Med (2001) 4.86
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.78
Making better use of research findings. BMJ (1998) 4.74
Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol (2001) 4.56
Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal (2001) 4.47
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.21
Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.14
Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med (1996) 3.59
Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet (2014) 3.53
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 3.49
A phenomenology of scut. Ann Intern Med (1991) 3.46
A brief clinical instrument to classify frailty in elderly people. Lancet (1999) 3.27
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ (1999) 3.14
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 3.10
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Analysis of data arising from a stratified design with the cluster as unit of randomization. Stat Med (1987) 3.01
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 2.98
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35
Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology (1967) 2.33
Adverse reproductive outcomes among women exposed to low levels of ionizing radiation from diagnostic radiography for adolescent idiopathic scoliosis. Epidemiology (1998) 2.27
Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology (1994) 2.10
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke (2006) 2.07
Reliability and validity characteristics of the Western Aphasia Battery (WAB). J Speech Hear Disord (1980) 2.07
Adjustments to the Mantel-Haenszel chi-square statistic and odds ratio variance estimator when the data are clustered. Stat Med (1987) 2.00
Conceptualisation and measurement of frailty in elderly people. Drugs Aging (2000) 2.00
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure. J Cell Biol (1985) 1.94
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int (2011) 1.91
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology (2004) 1.85
Functional reorganisation of memory after traumatic brain injury: a study with H(2)(15)0 positron emission tomography. J Neurol Neurosurg Psychiatry (2002) 1.74
Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology (2007) 1.71
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol (2010) 1.68
Competencies required for the practice of geriatric medicine as a consultant physician. CMAJ (1989) 1.67
The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke (1998) 1.67
Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol (1995) 1.66
Piloting short workshops on the critical appraisal of reviews. Health Trends (1996) 1.65
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology (2001) 1.64
The importance of lesion location in poststroke depression: a critical review. Can J Psychiatry (1998) 1.64
Recovery patterns and prognosis in aphasia. Brain (1977) 1.63
Episodic memory and the self in a case of isolated retrograde amnesia. Brain (1998) 1.62
The behavioural neurology assessment. Can J Neurol Sci (2005) 1.62
Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology (2001) 1.62
Bilateral movement enhances ipsilesional cortical activity in acute stroke: a pilot functional MRI study. Neurology (2001) 1.61
The Toronto traumatic brain injury study: injury severity and quantified MRI. Neurology (2008) 1.61
Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ (1999) 1.60
Line bisection in hemianopia. J Neurol Neurosurg Psychiatry (1998) 1.60
Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation (2002) 1.58
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians. CMAJ (1996) 1.57
The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes. Curr Med Res Opin (2014) 1.56
Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci (2001) 1.53
Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology (2003) 1.53
Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology (2000) 1.49
Effect of a geriatric consultation service on management of patients in an acute care hospital. CMAJ (1987) 1.48
The prevalence of cognitive impairment in an elderly Canadian population. Acta Psychiatr Scand (1989) 1.48
Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol (2007) 1.47
Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation (2001) 1.47
An overview of techniques for dealing with large numbers of independent variables in epidemiologic studies. Prev Vet Med (1997) 1.45
Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int (2011) 1.44
Effective dose equivalents to patients undergoing cerebral angiography. AJNR Am J Neuroradiol (1992) 1.44
Illness presentation in elderly patients. Arch Intern Med (1995) 1.43
Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci (1978) 1.43
Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med (1984) 1.40
Quantifying head motion associated with motor tasks used in fMRI. Neuroimage (2001) 1.39
Lesion size and location in ideomotor apraxia. Brain (1984) 1.39
Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart (1997) 1.38
Behavioral problems in nursing home residents. Safe ways to manage dementia. Postgrad Med (1995) 1.38
Lecture practices in United States anesthesiology residencies. Anesth Analg (1992) 1.38
Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol (2001) 1.38
The aphasia quotient: the taxonomic approach to measurement of aphasic disability. Can J Neurol Sci (1974) 1.36
Radiation-induced temporary epilation after a neuroradiologically guided embolization procedure. Radiology (1994) 1.35
Vascular dementia : incidence and risk factors in the Canadian study of health and aging. Stroke (2000) 1.35
Fine structure of a periciliary ridge complex of frog retinal rod cells revealed by ultrahigh resolution scanning electron microscopy. J Cell Biol (1983) 1.34
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. CMAJ (1999) 1.34
Differential stimulation of foetal rat liver uridine diphosphate glucuronyltransferase activity towards certain substrates after glucocorticoid treatment in culture and in utero, and during natural development [proceedings]. Biochem Soc Trans (1977) 1.34
A study of language functioning in Alzheimer patients. Brain Lang (1982) 1.34
A randomized trial of identification bracelets to prevent falls among patients in a rehabilitation hospital. Arch Phys Med Rehabil (1994) 1.33
Computer tomographic localization, lesion size, and prognosis in aphasia and nonverbal impairment. Brain Lang (1979) 1.33
Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol (1998) 1.32
A fused central incisor. Periodontal considerations in comprehensive treatment. J Periodontol (1985) 1.31
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer's disease. Neuropsychologia (1998) 1.30
The statistical analysis of multiple binary measurements. J Clin Epidemiol (1988) 1.30
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research. Stat Med (2008) 1.27
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci (2001) 1.27
Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps, and unidentified bright objects'. Arch Neurol (1988) 1.27
Triple "E" syndrome: bilateral locked posterior fracture dislocation of the shoulders. Neurology (2001) 1.27